Ethicon purchase failure triggers Focal termination
This article was originally published in Clinica
Executive Summary
Focal has exercised its right to terminate its distribution agreement with Johnson & Johnson subsidiary Ethicon in regard to Focal's proprietary surgical sealant. Focal said that Ethicon failed to meet the agreed minimum purchases and, under the terms of the contract, Focal gave Ethicon 90 days notice from this month.